AbbVie, M2GEN and Moffitt Cancer Center had a poster accepted and presented at virtual 62nd ASH Annual Meeting and Exposition entitled “Ex Vivo Drug Sensitivity and Functional Genomics Platform Identifies Novel Combinations Targeting Intrinsic and Extrinsic Apoptotic Signaling Pathways in Multiple Myeloma”
Due to the pandemic, ASH was conducted as a virtual conference. For this reason, ASH organizers had to come up with an alternative approach to how posters are traditionally presented. In lieu of a physical poster, organizers asked the authors to submit slide presentations which had to include oral narration not to exceed five minutes.
You can view the abstract here: https://doi.org/10.1182/blood-2020-134924